Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) (IMA)
Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) is the official source of medicine shortage information for Iceland (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- lyfjastofnun.is
- Country
- Iceland
- Notices tracked by Mederti
- 2,852
- Last checked
- 6 Aug 2026
Latest notices from IMA
- Iodixanolum — active, medium, since 5 Aug 2026 (source)
- Naloxonum — active, medium, since 4 Aug 2026 (source)
- Edoxabanum — active, low, since 4 Aug 2026 (source)
- Ketotifen Fumarate — active, medium, since 4 Aug 2026 (source)
- Atomoxetinum — active, medium, since 3 Aug 2026 (source)
- Olanzapinum — active, medium, since 3 Aug 2026 (source)
- Glucagonum — active, medium, since 3 Aug 2026 (source)
- Ifosfamidum — active, medium, since 2 Aug 2026 (source)
- Lisdexamfetaminum — active, medium, since 1 Aug 2026 (source)
- Edoxabano — active, medium, since 1 Aug 2026 (source)
- Simvastatinum — active, medium, since 1 Aug 2026 (source)
- Topiramatum — active, medium, since 1 Aug 2026 (source)
- Risperidonum — active, medium, since 1 Aug 2026 (source)
- Sitagliptin — active, medium, since 1 Aug 2026 (source)
- Repaglinidum — active, medium, since 1 Aug 2026 (source)
Every IMA notice, searchable and alertable
Search Iceland's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency). All notices remain the property of their publisher and are linked to the original source.